OLEMA PHARMACEUTICALS, INC. Conversion of Stock, Shares Converted
OLEMA PHARMACEUTICALS, INC. (OLMA) reported Conversion of Stock, Shares Converted of 23.77 million shares for the 1-month period ending 2020-11-30, per its 10-K filed 2022-02-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2022-02-28
- 2020-11-30: Conversion of Stock, Shares Converted 1 month 23.77M shares.
| Period end | Conversion of Stock, Shares Converted 1 month |
|---|---|
| 2020-11-30 | 23.77M shares 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |